Correlation Between Verrica Pharmaceuticals and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verrica Pharmaceuticals and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Verrica Pharmaceuticals and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and Pasithea Therapeutics.
Diversification Opportunities for Verrica Pharmaceuticals and Pasithea Therapeutics
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Verrica and Pasithea is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Verrica Pharmaceuticals and Pasithea Therapeutics
Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to generate 650.07 times less return on investment than Pasithea Therapeutics. But when comparing it to its historical volatility, Verrica Pharmaceuticals is 22.43 times less risky than Pasithea Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest 3.00 in Pasithea Therapeutics Corp on September 2, 2024 and sell it today you would lose (0.97) from holding Pasithea Therapeutics Corp or give up 32.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 52.02% |
| Values | Daily Returns |
Verrica Pharmaceuticals vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| Verrica Pharmaceuticals |
| Pasithea Therapeutics |
Verrica Pharmaceuticals and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verrica Pharmaceuticals and Pasithea Therapeutics
The main advantage of trading using opposite Verrica Pharmaceuticals and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.The idea behind Verrica Pharmaceuticals and Pasithea Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Pasithea Therapeutics vs. Tff Pharmaceuticals | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Inhibrx | Pasithea Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |